99 related articles for article (PubMed ID: 21626781)
1. [Carrageenan oligosaccharides inhibit growth-factor binding and heparanase activity].
Chen HM; Gao Y; Yan XJ
Yao Xue Xue Bao; 2011 Mar; 46(3):280-4. PubMed ID: 21626781
[TBL] [Abstract][Full Text] [Related]
2. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].
Chen HM; Yan XJ; Wang F; Lin J; Xu WF
Yao Xue Xue Bao; 2007 Jun; 42(6):595-600. PubMed ID: 17702394
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the binding of basic fibroblast growth factor and heparanase activity by purified λ-carrageenan oligosaccharides.
Niu TT; Zhang DS; Chen HM; Yan XJ
Carbohydr Polym; 2015 Jul; 125():76-84. PubMed ID: 25857962
[TBL] [Abstract][Full Text] [Related]
4. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
[TBL] [Abstract][Full Text] [Related]
5. Depolymerized products of lambda-carrageenan as a potent angiogenesis inhibitor.
Chen H; Yan X; Lin J; Wang F; Xu W
J Agric Food Chem; 2007 Aug; 55(17):6910-7. PubMed ID: 17661479
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
7. [Proliferation inhibition of lambda-carrageenan oligosaccharides on HUVEC and expression of apoptotic relevant genes].
Mi TY; Yan XJ; Chen HM; Lin J; Wang F; Xu WF
Yao Xue Xue Bao; 2008 May; 43(5):474-9. PubMed ID: 18717333
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic preparation of κ-carrageenan oligosaccharides and their anti-angiogenic activity.
Yao Z; Wu H; Zhang S; Du Y
Carbohydr Polym; 2014 Jan; 101():359-67. PubMed ID: 24299784
[TBL] [Abstract][Full Text] [Related]
10. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
11. λ-Carrageenan Oligosaccharides of Distinct Anti-Heparanase and Anticoagulant Activities Inhibit MDA-MB-231 Breast Cancer Cell Migration.
Groult H; Cousin R; Chot-Plassot C; Maura M; Bridiau N; Piot JM; Maugard T; Fruitier-Arnaudin I
Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30818840
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of binding of basic fibroblast growth factor to low and high affinity receptors by carrageenans.
Hoffman R; Sykes D
Biochem Pharmacol; 1993 Jun; 45(11):2348-51. PubMed ID: 8517877
[TBL] [Abstract][Full Text] [Related]
13. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis.
Ferro V; Dredge K; Liu L; Hammond E; Bytheway I; Li C; Johnstone K; Karoli T; Davis K; Copeman E; Gautam A
Semin Thromb Hemost; 2007 Jul; 33(5):557-68. PubMed ID: 17629854
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
Mikami S; Ohashi K; Katsube K; Nemoto T; Nakajima M; Okada Y
Pathol Int; 2004 Aug; 54(8):556-63. PubMed ID: 15260846
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of angiogenic activities of hyaluronan oligosaccharides of defined minimum size.
Cui X; Xu H; Zhou S; Zhao T; Liu A; Guo X; Tang W; Wang F
Life Sci; 2009 Oct; 85(15-16):573-7. PubMed ID: 19720068
[TBL] [Abstract][Full Text] [Related]
16. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
[TBL] [Abstract][Full Text] [Related]
17. Structural features in carrageenan that interact with a heparin-binding hematopoietic growth factor and modulate its biological activity.
Liang A; Zhou X; Wang Q; Liu X; Liu X; Du Y; Wang K; Lin B
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 843(1):114-9. PubMed ID: 16787766
[TBL] [Abstract][Full Text] [Related]
18. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.
Jayson GC; Gallagher JT
Br J Cancer; 1997; 75(1):9-16. PubMed ID: 9000592
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic Agent.
Poupard N; Badarou P; Fasani F; Groult H; Bridiau N; Sannier F; Bordenave-Juchereau S; Kieda C; Piot JM; Grillon C; Fruitier-Arnaudin I; Maugard T
Mar Drugs; 2017 May; 15(5):. PubMed ID: 28486399
[TBL] [Abstract][Full Text] [Related]
20. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
Forsten KE; Courant NA; Nugent MA
J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
